X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The U.S. Court of Appeals for the D.C. Circuit handed the drug industry a win last week when it ruled that the District does not have a right to control the price of prescription drugs sold in the city. The Pharmaceutical Research and Manufacturers Association, a drug industry trade group, moved quickly in December 2005 to block the new law before it could be implemented. WilmerHale partner David Ogden represented PhRMA and argued the case before the D.C. Circuit and the U.S. District Court. Partner Randolph Moss also worked on the case, along with counsel Brian Boyton and associates Anne Small and Catherine Carroll. The three-judge appellate panel of Judges Arthur Gajarsa, William Bryson, and Senior Judge S. Jay Plager found that while the D.C. Council and then-Mayor Anthony Williams might have had good intentions to protect D.C. residents from high costs, the law nevertheless violates federal patent law. “This may be a worthy undertaking on the part of the District government, but it is contrary to the goals established by Congress in the patent laws,” the panel wrote.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.